Buy Fetroja in India — Price & Availability

Fetroja (cefiderocol) is a cephalosporin antibacterial with a unique “siderophore” mechanism: it binds iron and is carried into Gram-negative bacteria through their iron-transport systems (a “Trojan horse” mechanism), then acts like other beta-lactams to disrupt the bacterial cell wall. It is active against many multidrug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa.

It is approved for patients 18 years of age and older for:

• Complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible Gram-negative microorganisms, in patients who have limited or no alternative treatment options.
• Hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible Gram-negative microorganisms.

To reduce the development of drug-resistant bacteria, Fetroja should be used only to treat infections proven or strongly suspected to be caused by susceptible bacteria. It is a prescription medicine and must be used under physician supervision.

Recommended dosage:
The recommended dose of Fetroja is 2 grams administered every 8 hours by intravenous infusion over 3 hours, in patients with normal or mildly reduced kidney function. The dose is adjusted for patients with reduced or increased kidney clearance, as described in the prescribing information. The usual treatment duration is 7 to 14 days, guided by the site and severity of infection and the patient’s clinical response. Fetroja is given only as a reconstituted and diluted IV infusion. The treating physician always determines the exact dose and duration.

• Increased Risk of Mortality: In one clinical study, patients with certain drug-resistant Gram-negative infections treated with Fetroja had a higher overall mortality than those receiving other treatments. Your doctor will monitor your response carefully.
• Hypersensitivity Reactions: Fetroja may cause serious allergic reactions, including anaphylaxis. Inform your doctor if you have a history of penicillin or cephalosporin allergy. Seek immediate medical attention if allergic symptoms develop.
• Clostridioides difficile-Associated Diarrhoea: Fetroja may cause severe diarrhoea due to Clostridioides difficile infection. Contact your doctor promptly if you experience persistent, severe, or bloody diarrhoea during or after treatment.
• Seizures and Central Nervous System Reactions: Seizures, tremors, confusion, or muscle jerks have been reported with cephalosporin antibiotics, including Fetroja. Inform your doctor immediately if you experience any unusual neurological symptoms during treatment.

Common side effects:
The most common side effects include diarrhoea, infusion-site reactions, constipation, rash, candidiasis, cough, elevated liver tests, headache, low potassium, nausea, and vomiting. This is not a complete list — refer to the full prescribing information and your doctor

Patients in India can legally access Fetroja through the Named Patient Program (NPP) — an import route that allows a medicine not yet registered in India to be imported in an individual patient’s name, on their physician’s prescription. The process is simple and fully documented:

• Share your request — the patient or treating doctor sends the medicine name, required quantity, and destination city.
• Eligibility & document check — we verify the prescription, diagnostic reports, and patient ID against regulatory requirements.
• Receive your quote — a transparent quotation covering medicine cost, logistics, and timeline.
  Regulatory approvals — we assist with the import permit and documentation needed for legal cross-border access.
• Import & delivery — Fetroja is sourced and shipped under validated, temperature-controlled conditions to the patient or treating hospital.

Documents required to import Fetroja:

• A valid prescription from a qualified physician
• The patient’s diagnostic reports (including culture/susceptibility results where available)
• Government-issued patient ID proof
• An import permit, where applicable

Because Fetroja is not sold on the open market in India, there is no fixed MRP. The Fetroja cost in India depends on a few factors at the time of import:

• The number of 1 g vials required, which is based on the prescribed dose (typically 2 g every 8 hours), the infusion schedule, kidney function, and the treatment duration.
• The sourcing country and current ex-market price (USA, Europe, Canada, Japan, China, or Australia).
• Logistics, insurance, and any applicable customs duties or import permit costs.

Get a transparent quote: We provide a written quotation covering Fetroja cost, logistics, and delivery timeline once a valid prescription is shared. Request your Fetroja quote →

Fetroja is a prescription-only medicine. Pricing is shared with patients, caregivers, and treating hospitals against a valid prescription, in line with applicable regulations.

Indian Pharma Network sources Fetroja from reliable manufacturers and authorised supply channels and facilitates supply to patients, doctors, and hospitals under applicable legal provisions. Fetroja vials should be stored according to the conditions stated on the dispensed carton and package leaflet, in the original packaging, protected from light. All orders are dispensed and checked by registered pharmacists and dispatched after legal requirements are fulfilled.

Is Fetroja available in India?

Fetroja (cefiderocol injections) is a prescription medicine that legally requires a doctor’s prescription to be dispensed. As of the current publicly available information, Fetroja is not commercially marketed in India.

However, patients in India can legally access Fetroja through the Named Patient Program (NPP) — an import provision that allows a medicine not yet registered in India to be imported in the name of an individual patient, on the prescription of their treating physician.

Indian Pharma Network (IPN) acts as a facilitator under named patient supply, providing input on:
Availability of Fetroja in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.) and pathways to access it
Availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
Fetroja price in India under the NPP route
Sourcing from genuine, reliable channels in the USA, Canada, Europe, and Australia
Ensuring full transparency throughout the process

Fetroja can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others — and can facilitate delivery to the patient’s treating hospital. Orders are confirmed only upon receipt of a valid doctor’s prescription and, where applicable, an import permit.

Regulatory approval status:
Fetroja first received US FDA approval in November 2019 for complicated urinary tract infections (including pyelonephritis) in adults with limited or no alternative treatment options, with a later approval for hospital-acquired/ventilator-associated bacterial pneumonia. It was designated a Qualified Infectious Disease Product with fast-track and priority review. In the European Union, it was approved (April 2020) under the brand name Fetroja for infections due to aerobic Gram-negative bacteria in adults with limited treatment options. As of the current publicly available information, Fetroja is not commercially marketed in India, which is why the Named Patient route is used.